@deepnewz
๐ฐ VC Brief
๐ฏ Novo Nordisk inks $550M Replicate deal; Reliance plans Jio IPO, AI push; Microsoft launches in-house AI.
๐ธ Novo Nordisk signs a $550M licensing deal with Replicate Bioscience for self-replicating RNA obesity drugs, expanding beyond GLP-1 therapies.
Read more: ๐งต